Comparing direct oral anticoagulants and vitamin K antagonist use in morbidly obese patients with venous thromboembolism: A single center retrospective cohort study

Introduction: Limited data exists on the safety and efficacy of direct‐acting oral anticoagulants (DOAC) use in morbidly obese patients with venous thromboembolism (VTE). Given the benefits of DOAC use over vitamin K antagonists (VKAs), in terms of monitoring requirements, and dietary and drug inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Lia C., Li, Juan, Cafuir, Lorraine A., Gaddh, Manila, Kempton, Christine L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175804/
https://www.ncbi.nlm.nih.gov/pubmed/35846040
http://dx.doi.org/10.1002/jha2.418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175804/
https://www.ncbi.nlm.nih.gov/pubmed/35846040
http://dx.doi.org/10.1002/jha2.418

Ejemplares similares